drugset

drugset / Trial / NCT00004810

Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis

NCT00004810 ↗

Phase 2 Completed 30 enrolled National Center for Research Resources (NCRR) University of Vermont · collab

RandomizedTreatment

Summary

OBJECTIVES: I. Assess the safety and efficacy of 4-aminosalicylic acid in patients with mildly to moderately severe ulcerative colitis.

Timeline

Start: 1996-06
Primary completion: —
Completion: —

Publications

Background Beeken W, Howard D, Bigelow J, Trainer T, Roy M, Thayer W, Wild G. Controlled trial of 4-ASA in ulcerative colitis. Dig Dis Sci. 1997 Feb;42(2):354-8. doi: 10.1023/a:1018874120749.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	4-Aminosalicylic acid	Unknown	—	Oral

Indications